Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intercure Ltd. - ordinary shares (NQ:INCR)

0.7551 -0.0148 (-1.92%)
Streaming Delayed Price Updated: 10:40 AM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intercure Ltd. - ordinary shares

< Previous 1 2 3 4 Next >
News headline image
InterCure Enters Premium US Cannabis Market With ISHI Deal ↗
InterCure Ltd. (NASDAQ: INCR) acquires Botanico Ltd., known as ISHI, to strengthen its global cannabis portfolio. 
Via Benzinga
Topics Cannabis
InterCure To Buy ISHI In All-Stock Transaction – Find Out More ↗
Via Stocktwits
News headline image
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company ↗
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A. 
Via Benzinga
News headline image
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany ↗
 
Via Benzinga
Topics Cannabis
News headline image
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
From InterCure
Via Business Wire
News headline image
5 Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon ↗
Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling... 
Via Benzinga
Topics Cannabis
News headline image
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ ↗
The potential rescheduling of cannabis in the U.S. 
Via Benzinga
Topics Cannabis
News headline image
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
From InterCure Ltd.
Via Business Wire
News headline image
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion ↗
"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges. 
Via Benzinga
News headline image
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
From InterCure Ltd.
Via Business Wire
News headline image
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict ↗
Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany. 
Via Benzinga
Topics Cannabis
News headline image
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
From InterCure Ltd.
Via Business Wire
News headline image
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
From InterCure Ltd.
Via Business Wire
News headline image
Canndoc Reports Record Revenue Amid Cannabis Market Turmoil ↗
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023, 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For August 18, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From August 24, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
News headline image
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Medical Cannabis Company Better Is Suing InterCure For $35M ↗
Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million. 
Via Benzinga
News headline image
InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details ↗
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million)... 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From August 14, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Why Are Cannabis Stocks Trading Higher Today? ↗
Cannabis stocks shot up in Thursday's pre-market and are holding. 
Via Benzinga
News headline image
Cannabis Stock Movers For August 10, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries ↗
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership. 
Via Benzinga
News headline image
Nasdaq Down 80 Points; VirTra Shares Spike Higher ↗
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P... 
Via Benzinga
News headline image
Marijuana Stock Movers For August 9, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For August 8, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For July 24, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.